ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Sodium Bicarbonate → Oritavancin

HRID 1397114
ノート
印刷プレビュー

反応式

HRID 1397114 の反応式
[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@H:9]2[C@@H:100]3[NH:101][C:102](=[O:103])[C@@H:81]([C:82]4[CH:83]=[CH:84][C:85]([OH:107])=[C:86]([C:88]5[C:93]([OH:94])=[CH:92][C:91]([OH:95])=[CH:90][C:89]=5[C@@H:96]([C:104]([OH:106])=[O:105])[NH:97][C:98]3=[O:99])[CH:87]=4)[NH:80][C:78](=[O:79])[C@H:77]3[C:20]4=[CH:21][C:22]([O:60][C:61]5[CH:62]=[CH:63][C:64]([C@@H:68]([OH:122])[C@@H:69]([NH:112][C:113]([C@H:115]([NH:120][CH3:121])[CH2:116][CH:117]([CH3:119])[CH3:118])=[O:114])[C:70]([NH:72][C@@H:73]([CH2:108][C:109]([NH2:111])=[O:110])[C:74]([NH:76]3)=[O:75])=[O:71])=[CH:65][C:66]=5[Cl:67])=[C:23]([O:24][C@@H:25]3[O:30][C@H:29]([CH2:31][OH:32])[C@@H:28]([OH:33])[C@H:27]([OH:34])[C@H:26]3[O:35][C@@H:36]3[O:41][C@@H:40]([CH3:42])[C@H:39]([OH:43])[C@:38]([NH:45][CH2:46][C:47]5[CH:48]=[CH:49][C:50]([C:53]6[CH:54]=[CH:55][C:56]([Cl:59])=[CH:57][CH:58]=6)=[CH:51][CH:52]=5)([CH3:44])[CH2:37]3)[C:18](=[CH:19]4)[O:17][C:13]3=[C:14]([Cl:16])[CH:15]=[C:10]2[CH:11]=[CH:12]3)[CH2:5][C@@:4]([NH2:124])([CH3:123])[C@H:3]1[OH:125].OP(O)(O)=O.C([O-])(O)=O.[Na+].C(OC(N(CCCN(C(OC(C)(C)C)=O)CCCCN(C(OC(C)(C)C)=O)CCCNC(OC(C)(C)C)=O)CC(O)=O)=O)(C)(C)C>O1CCOCC1.O>[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@H:9]2[C@@H:100]3[NH:101][C:102](=[O:103])[C@@H:81]([C:82]4[CH:83]=[CH:84][C:85]([OH:107])=[C:86]([C:88]5[C:93]([OH:94])=[CH:92][C:91]([OH:95])=[CH:90][C:89]=5[C@@H:96]([C:104]([OH:106])=[O:105])[NH:97][C:98]3=[O:99])[CH:87]=4)[NH:80][C:78](=[O:79])[C@H:77]3[C:20]4=[CH:21][C:22]([O:60][C:61]5[CH:62]=[CH:63][C:64]([C@@H:68]([OH:122])[C@@H:69]([NH:112][C:113]([C@H:115]([NH:120][CH3:121])[CH2:116][CH:117]([CH3:118])[CH3:119])=[O:114])[C:70]([NH:72][C@@H:73]([CH2:108][C:109]([NH2:111])=[O:110])[C:74]([NH:76]3)=[O:75])=[O:71])=[CH:65][C:66]=5[Cl:67])=[C:23]([O:24][C@@H:25]3[O:30][C@H:29]([CH2:31][OH:32])[C@@H:28]([OH:33])[C@H:27]([OH:34])[C@H:26]3[O:35][C@@H:36]3[O:41][C@@H:40]([CH3:42])[C@H:39]([OH:43])[C@:38]([NH:45][CH2:46][C:47]5[CH:52]=[CH:51][C:50]([C:53]6[CH:58]=[CH:57][C:56]([Cl:59])=[CH:55][CH:54]=6)=[CH:49][CH:48]=5)([CH3:44])[CH2:37]3)[C:18](=[CH:19]4)[O:17][C:13]3=[C:14]([Cl:16])[CH:15]=[C:10]2[CH:11]=[CH:12]3)[CH2:5][C@@:4]([NH2:124])([CH3:123])[C@H:3]1[OH:125]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 516892Sodium BicarbonateHCID 11006845N3,N7,N12,N16-Tetra(t-butoxycarbonyl)-3,7,12,16-tetraazahexadecanoic acidHCID 70691404171099-57-3(Free base)

生成物 1

HCID 16136912Oritavancin

試薬・触媒・溶媒 2

HCID 962
Water
溶媒
HCID 312751,4-Dioxane溶媒2 回

実験手順

To oritavancin bisphosphoric acid salt (5, 223 mg, 0.112 mmol) in 1,4-dioxane (5 mL) and H2O (6 mL) was added NaHCO3 (29 mg, 0.35 mmol) and the mixture was stirred until all of 5 had dissolved. A solution of 31 (125 mg, 0.165 mmol) in 1,4-dioxane (2 mL) was added and the resulting solution was stirred at room temperature overnight. The product was precipitated by the addition of H2O and collected by filtration. The crude product was purified by C18 reversed phase chromatography on a Biotage™ flash chromatography system (30% to 80% MeCN in 0.2% TEA/phosphate pH 3) to give 35 (110 mg, 37%, based on the di-phosphoric acid salt) as a white solid: ESI-MS (M+2H) calculated for C118H155Cl3N14O35, 1218.9. found 1218.4.

後処理

  1. dissolutionhad dissolved
  2. stirringthe resulting solution was stirred at room temperature overnight
  3. customThe product was precipitated by the addition of H2O
  4. filtrationcollected by filtration
  5. customThe crude product was purified by C18 reversed phase chromatography on a Biotage™ flash chromatography system (30% to 80% MeCN in 0.2% TEA/phosphate pH 3)

出典と根拠

ORDレコード
ord-5ae4601183914af2b4506b9ee9f87aaf
出典データセット
uspto-grants-2014_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08901072B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート